- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GAL- GLA: alpha-D-galactopyranose-(1-3)-beta-D-galactopyranose(Non-covalent)
- 3 x MLT: D-MALATE(Non-covalent)
MLT.2: 4 residues within 4Å:- Chain A: I.168, N.169, E.170
- Chain B: F.227
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:N.169
- Hydrogen bonds: A:E.170
- Water bridges: A:A.171
MLT.50: 5 residues within 4Å:- Chain A: H.390, I.395, Y.397, R.424, F.525
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Y.397
- Hydrogen bonds: A:Y.397, A:Y.397
- Salt bridges: A:H.390, A:R.424
MLT.54: 3 residues within 4Å:- Chain B: D.190, R.191, R.194
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:R.191
- Water bridges: B:R.191
- Salt bridges: B:R.191, B:R.194
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 5 residues within 4Å:- Chain A: K.363, V.403, Q.416, F.417, I.418
Ligand excluded by PLIPEDO.4: 2 residues within 4Å:- Chain A: K.304
- Ligands: IOD.24
Ligand excluded by PLIPEDO.5: 3 residues within 4Å:- Chain A: T.528, S.529, R.530
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: E.201
- Chain B: K.207, F.227, G.229, N.230, K.263
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: H.286, P.310, S.311, K.312
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: G.154, P.248
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: L.237, N.238, D.241, V.242
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: R.217, P.310, E.340, S.341, K.449
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: S.493, K.533, N.534
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: A.151, G.152
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: I.592, S.593, I.594
Ligand excluded by PLIPEDO.55: 4 residues within 4Å:- Chain B: K.498, K.538, G.539, N.563
Ligand excluded by PLIPEDO.56: 4 residues within 4Å:- Chain B: I.584, I.590, P.611
- Ligands: IOD.86
Ligand excluded by PLIPEDO.57: 3 residues within 4Å:- Chain B: R.448, Y.469, H.471
Ligand excluded by PLIPEDO.58: 3 residues within 4Å:- Chain B: I.592, S.593, I.594
Ligand excluded by PLIPEDO.59: 2 residues within 4Å:- Chain B: K.66, N.109
Ligand excluded by PLIPEDO.60: 5 residues within 4Å:- Chain B: M.81, Y.82, Q.296, R.297, G.376
Ligand excluded by PLIPEDO.61: 4 residues within 4Å:- Chain B: H.390, I.395, Y.397, R.424
Ligand excluded by PLIPEDO.62: 1 residues within 4Å:- Chain B: F.181
Ligand excluded by PLIPEDO.63: 4 residues within 4Å:- Chain B: A.149, D.157, K.159, V.242
Ligand excluded by PLIPEDO.64: 6 residues within 4Å:- Chain B: R.460, G.491, V.492, R.530, Y.531, K.533
Ligand excluded by PLIPEDO.65: 7 residues within 4Å:- Chain A: T.44, H.45, Y.48, R.75, A.77
- Chain B: R.407, V.408
Ligand excluded by PLIPEDO.66: 5 residues within 4Å:- Chain B: R.217, P.310, E.340, S.341, K.449
Ligand excluded by PLIPEDO.67: 3 residues within 4Å:- Chain B: H.286, S.311, K.312
Ligand excluded by PLIP- 59 x IOD: IODIDE ION(Non-functional Binders)
IOD.14: 4 residues within 4Å:- Chain A: R.297, N.327, F.379, K.433
Ligand excluded by PLIPIOD.15: 4 residues within 4Å:- Chain A: K.207, R.208, F.227
- Ligands: IOD.23
Ligand excluded by PLIPIOD.16: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.17: 1 residues within 4Å:- Chain A: K.577
Ligand excluded by PLIPIOD.18: 2 residues within 4Å:- Chain A: K.66, N.108
Ligand excluded by PLIPIOD.19: 4 residues within 4Å:- Chain A: K.55, S.99, F.100, N.101
Ligand excluded by PLIPIOD.20: 3 residues within 4Å:- Chain A: R.68, H.115, S.139
Ligand excluded by PLIPIOD.21: 3 residues within 4Å:- Chain A: H.371, Q.373
- Chain B: K.195
Ligand excluded by PLIPIOD.22: 2 residues within 4Å:- Chain A: I.594, S.606
Ligand excluded by PLIPIOD.23: 2 residues within 4Å:- Chain A: F.227
- Ligands: IOD.15
Ligand excluded by PLIPIOD.24: 2 residues within 4Å:- Chain A: K.443
- Ligands: EDO.4
Ligand excluded by PLIPIOD.25: 4 residues within 4Å:- Chain A: C.328, I.349, R.435, A.438
Ligand excluded by PLIPIOD.26: 2 residues within 4Å:- Chain A: R.575, K.577
Ligand excluded by PLIPIOD.27: 3 residues within 4Å:- Chain A: T.404, T.406, R.414
Ligand excluded by PLIPIOD.28: 1 residues within 4Å:- Chain A: K.153
Ligand excluded by PLIPIOD.29: 6 residues within 4Å:- Chain A: R.79, I.93, P.96, L.97, S.98, I.122
Ligand excluded by PLIPIOD.30: 2 residues within 4Å:- Chain A: S.587, I.590
Ligand excluded by PLIPIOD.31: 1 residues within 4Å:- Chain A: F.33
Ligand excluded by PLIPIOD.32: 2 residues within 4Å:- Chain A: R.233, F.246
Ligand excluded by PLIPIOD.33: 3 residues within 4Å:- Chain A: D.162, Q.163
- Ligands: MLA.46
Ligand excluded by PLIPIOD.34: 1 residues within 4Å:- Chain A: K.401
Ligand excluded by PLIPIOD.35: 2 residues within 4Å:- Chain A: K.426, E.427
Ligand excluded by PLIPIOD.36: 3 residues within 4Å:- Chain A: T.329, R.435, S.436
Ligand excluded by PLIPIOD.37: 2 residues within 4Å:- Chain A: R.92
- Chain B: N.410
Ligand excluded by PLIPIOD.38: 3 residues within 4Å:- Chain A: T.406, R.414
- Chain B: H.45
Ligand excluded by PLIPIOD.39: 2 residues within 4Å:- Chain A: F.601, S.602
Ligand excluded by PLIPIOD.40: 3 residues within 4Å:- Chain A: K.207, F.227, K.263
Ligand excluded by PLIPIOD.41: 1 residues within 4Å:- Chain A: I.168
Ligand excluded by PLIPIOD.42: 3 residues within 4Å:- Chain A: N.499, K.538, G.539
Ligand excluded by PLIPIOD.43: 4 residues within 4Å:- Chain A: K.207, R.208, R.265
- Ligands: GAL-GLA.1
Ligand excluded by PLIPIOD.44: 4 residues within 4Å:- Chain A: K.331, K.333, I.441
- Ligands: MLI.47
Ligand excluded by PLIPIOD.45: 2 residues within 4Å:- Chain A: D.523, K.524
Ligand excluded by PLIPIOD.68: 4 residues within 4Å:- Chain B: R.297, N.327, F.379, K.433
Ligand excluded by PLIPIOD.69: 1 residues within 4Å:- Chain B: F.33
Ligand excluded by PLIPIOD.70: 3 residues within 4Å:- Chain B: R.208, F.227
- Ligands: IOD.80
Ligand excluded by PLIPIOD.71: 1 residues within 4Å:- Chain B: K.304
Ligand excluded by PLIPIOD.72: 1 residues within 4Å:- Chain B: E.427
Ligand excluded by PLIPIOD.73: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.74: 3 residues within 4Å:- Chain A: K.195, Q.199
- Chain B: Q.373
Ligand excluded by PLIPIOD.75: 2 residues within 4Å:- Chain B: R.68, S.139
Ligand excluded by PLIPIOD.76: 1 residues within 4Å:- Chain B: K.577
Ligand excluded by PLIPIOD.77: 2 residues within 4Å:- Chain B: D.523, K.524
Ligand excluded by PLIPIOD.78: 2 residues within 4Å:- Chain B: R.575, K.577
Ligand excluded by PLIPIOD.79: 1 residues within 4Å:- Chain B: P.248
Ligand excluded by PLIPIOD.80: 2 residues within 4Å:- Chain B: D.225
- Ligands: IOD.70
Ligand excluded by PLIPIOD.81: 4 residues within 4Å:- Chain B: C.328, I.349, R.435, A.438
Ligand excluded by PLIPIOD.82: 3 residues within 4Å:- Chain B: T.404, T.406, R.414
Ligand excluded by PLIPIOD.83: 2 residues within 4Å:- Chain A: H.45
- Chain B: R.414
Ligand excluded by PLIPIOD.84: 5 residues within 4Å:- Chain B: R.79, I.93, P.96, S.98, I.122
Ligand excluded by PLIPIOD.85: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.86: 3 residues within 4Å:- Chain B: S.587, I.590
- Ligands: EDO.56
Ligand excluded by PLIPIOD.87: 1 residues within 4Å:- Chain B: I.168
Ligand excluded by PLIPIOD.88: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.89: 2 residues within 4Å:- Chain A: N.410
- Chain B: R.92
Ligand excluded by PLIPIOD.90: 3 residues within 4Å:- Chain B: T.329, R.435, S.436
Ligand excluded by PLIPIOD.91: 2 residues within 4Å:- Chain B: D.162, Q.163
Ligand excluded by PLIPIOD.92: 1 residues within 4Å:- Chain B: S.602
Ligand excluded by PLIPIOD.93: 3 residues within 4Å:- Chain B: K.401, I.418, K.419
Ligand excluded by PLIPIOD.94: 3 residues within 4Å:- Chain B: I.594, K.605, S.606
Ligand excluded by PLIP- 1 x MLA: MALONIC ACID(Non-covalent)
- 1 x MLI: MALONATE ION(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McGuire, B.E. et al., The structure of a family 110 glycoside hydrolase provides insight into the hydrolysis of alpha-1,3-galactosidic linkages in lambda-carrageenan and blood group antigens. J.Biol.Chem. (2020)
- Release Date
- 2020-11-04
- Peptides
- Glycoside hydrolase family 110: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GAL- GLA: alpha-D-galactopyranose-(1-3)-beta-D-galactopyranose(Non-covalent)
- 3 x MLT: D-MALATE(Non-covalent)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 59 x IOD: IODIDE ION(Non-functional Binders)
- 1 x MLA: MALONIC ACID(Non-covalent)
- 1 x MLI: MALONATE ION(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McGuire, B.E. et al., The structure of a family 110 glycoside hydrolase provides insight into the hydrolysis of alpha-1,3-galactosidic linkages in lambda-carrageenan and blood group antigens. J.Biol.Chem. (2020)
- Release Date
- 2020-11-04
- Peptides
- Glycoside hydrolase family 110: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
C